Suppression of development of anti-nuclear antibody and glomerulonephritis in NZB x NZWF1 mice by persistent infection with lactic dehydrogenase virus: possible involvement of superoxide anion as a progressive effector

Int J Exp Pathol. 1993 Dec;74(6):553-60.

Abstract

The development of anti-nuclear antibody (ANA) and glomerulonephritis (GN) in autoimmune NZB x NZWF1 mice was suppressed by persistent lactic dehydrogenase virus (LDV) infection. This observation was used to study a possible pathogenetic role for the toxic oxygen radical, superoxide anion (O2-), in the progression of ANA and GN. Compared to macrophages from NZB x NZWF1 mice with LDV infection, macrophages from uninfected NZB x NZWF1 mice exhibited an age-related and drastic increase in O2- production in association with the development of the ANA and GN (representing the late stage of disease). NZB x NZWF1 mice with or without LDV infection were then given the O2- scavenger superoxide dismutase (SOD) during the late stage of the disease. Treatment of uninfected NZB x NZWF1 mice with SOD (10,000 units/mouse/day for 3 weeks) protected animals from the development of ANA and GN. SOD treatment also suppressed the development of the lesions in NZB x NZWF1 mice with LDV infection. Our findings suggest that O2- may, at least in part, contribute to the development of ANA and GN in the late stage of disease, and that decreased O2- production in NZB x NZWF1 mice with LDV infection may be responsible for the suppression of the development of ANA and GN in the late stage of the disease.

MeSH terms

  • Aging / immunology
  • Animals
  • Antibodies, Antinuclear / biosynthesis*
  • Arterivirus Infections / immunology*
  • Autoimmune Diseases / immunology
  • Autoimmune Diseases / prevention & control
  • Female
  • Fluorescent Antibody Technique
  • Glomerulonephritis / immunology*
  • Glomerulonephritis / prevention & control
  • Immunoglobulin G / analysis
  • Lactate dehydrogenase-elevating virus*
  • Macrophages / metabolism
  • Mice
  • Mice, Inbred NZB
  • Superoxide Dismutase / therapeutic use
  • Superoxides / immunology*
  • Superoxides / metabolism

Substances

  • Antibodies, Antinuclear
  • Immunoglobulin G
  • Superoxides
  • Superoxide Dismutase